Intervention Review

Meglitinide analogues for type 2 diabetes mellitus

  1. Corri Black1,*,
  2. Peter Donnelly2,
  3. Linda McIntyre3,
  4. Pamela Royle4,
  5. Jonathan J Shepherd5,
  6. Sian Thomas3

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 30 OCT 2006

DOI: 10.1002/14651858.CD004654.pub2

How to Cite

Black C, Donnelly P, McIntyre L, Royle P, Shepherd JJ, Thomas S. Meglitinide analogues for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD004654. DOI: 10.1002/14651858.CD004654.pub2.

Author Information

  1. 1

    University of Aberdeen, Department of Public Health, Aberdeen, Scotland, UK

  2. 2

    University of Aberdeen, Population Health, Aberdeen, UK

  3. 3

    c/o University of Aberdeen, Aberdeen, UK

  4. 4

    University of Aberdeen, School of Medicine, Department of Public Health, Aberdeen, UK

  5. 5

    University of Southampton, NCCHTA, Wessex Institute for Health Research and Development, Southampton, Hants, UK

*Corri Black, Department of Public Health, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, Scotland, AB25 2ZD, UK. corri.black@abdn.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

  1. Current Version

    Meglitinide analogues for type 2 diabetes mellitus

    Corri Black, Peter Donnelly, Linda McIntyre, Pamela Royle, Jonathan J Shepherd and Sian Thomas

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD004654.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Meglitinide analogues for type 2 diabetes mellitus

    C Black, L McIntyre, JA Mesa-Perez, PL Royle, S Thomas and N Waugh

    Article first published online: 24 JAN 2007 | DOI: 10.1002/14651858.CD004654